Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to investigate the impact of integrating aerobic, respiratory and cognitive training in acute heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedStudy Start
First participant enrolled
March 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedMarch 3, 2026
February 1, 2026
2 months
February 26, 2026
February 26, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Functional Exercise Capacity
Functional exercise capacity will be assessed using the Six-Minute Walk Test (6MWT), a standardized submaximal exercise test that measures the total distance walked on a flat surface within six minutes. The 6MWT reflects the integrated performance of the cardiovascular, respiratory, and musculoskeletal systems and is a clinically meaningful indicator of functional status in patients with acute heart failure.
3 weeks
Peak Oxygen Consumption
Peak oxygen consumption (VO₂ peak) will be estimated using the validated prediction equation developed by Vanhelst et al., which incorporates six-minute walk distance and body mass index. This method provides an indirect assessment of aerobic capacity and cardiorespiratory fitness in patients who are unable to perform maximal exercise testing during hospitalization.
3 weeks
Inspiratory Muscle Strength
Inspiratory muscle strength will be evaluated by measuring maximal inspiratory pressure (MIP or PImax) using a calibrated manometer. This measurement quantifies the maximum static inspiratory pressure generated against an occluded airway and reflects the functional capacity of the inspiratory muscles.
3 weeks
Expiratory Muscle Strength
Expiratory muscle strength will be assessed by measuring maximal expiratory pressure (MEP or PEmax) using a standardized manometer. MEP represents the maximal static pressure produced during forced expiration against an occluded airway and provides an objective measure of global expiratory muscle function.
3 weeks
Cognitive Function
Cognitive function will be assessed using the validated Arabic version of the Montreal Cognitive Assessment (MoCA). This tool evaluates multiple cognitive domains, including attention, memory, executive function, language, and visuospatial abilities, and is suitable for detecting cognitive impairment in patients with acute heart failure.
3 weeks
Secondary Outcomes (1)
cardiac troponins
3 weeks
Study Arms (2)
Aerobic training + Inspiratory muscle training + Cognitive training + Conventional therapy
EXPERIMENTALTwenty patients will receive a comprehensive intervention program consisting of aerobic training, inspiratory muscle training, and cognitive training in addition to conventional therapy. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.
Conventional therapy
ACTIVE COMPARATORTwenty patients will receive conventional therapy only. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.
Interventions
Participants in the experimental group will receive arm ergometer training performed at the bedside for 10-15 minutes, twice daily, at low-to-moderate intensity corresponding to 40-50% of the age-predicted maximum heart rate, under appropriate monitoring. The intervention will be continued throughout the hospitalization period for a minimum duration of three weeks.
Participants in the experimental group will receive inspiratory muscle training using a threshold device set at 30% of maximal inspiratory pressure, performed twice daily for 15 minutes per session. The training load will be progressively increased according to patient tolerance, and the intervention will be continued throughout the hospitalization period for a minimum duration of three weeks.
Participants in the experimental group will receive computerized cognitive training consisting of 20-minute daily sessions targeting attention, memory, and problem-solving abilities. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.
Participants in both groups will receive conventional therapy. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.
Eligibility Criteria
You may qualify if:
- Age between 50-65 years.
- All patients are male.
- Diagnosed with acute heart failure according to ESC guidelines.
- Hemodynamically stable for at least 24 hours.
- Able to follow simple verbal commands and participate in training.
You may not qualify if:
- Unstable angina or recent myocardial infarction (\< 4 weeks).
- Severe uncontrolled arrhythmias or advanced atrioventricular block.
- Severe pulmonary disease (e.g., advanced COPD, restrictive lung disease).
- Neurological disorders causing cognitive or motor disability.
- Orthopedic or musculoskeletal conditions preventing upper-limb activity.
- Severe visual or auditory impairment limiting participation in cognitive training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cardiology department at El-Kasr El Einy University hospital
Giza, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Azza Abdel Aziz, PhD
Ass. Professor, Cairo University
- STUDY DIRECTOR
Alaa Mohamed Naguib, PhD
Lecturer, Cairo University
- STUDY DIRECTOR
Ahmed Mohamed Abdelmegeed ElFeky
Lecturer, Misr University for science and technology
Central Study Contacts
Alaa Mohamed Naguib, PhD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 3, 2026
Study Start
March 7, 2026
Primary Completion
April 22, 2026
Study Completion
April 30, 2026
Last Updated
March 3, 2026
Record last verified: 2026-02